{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:59:22Z","timestamp":1784329162854,"version":"3.55.0"},"reference-count":169,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ajpc.2022.100432","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T02:02:20Z","timestamp":1668564140000},"page":"100432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5655-2769","authenticated-orcid":false,"given":"Charles A.","family":"German","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth J.","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith C.","family":"Ferdinand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar S.","family":"Polonsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpc.2022.100432_bib0001","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the American heart association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0002","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.jacc.2015.03.018","article-title":"COCATS 4 task force 2: training in preventive cardiovascular medicine","volume":"65","author":"Smith","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0003","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.amjcard.2012.02.059","article-title":"Current status of preventive cardiology training among united states cardiology fellowships and comparison to training guidelines","volume":"110","author":"Pack","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0004","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/clc.22590","article-title":"The American society for preventive cardiology: our 30-year legacy","volume":"39","author":"Wong","year":"2016","journal-title":"Clinical cardiology"},{"key":"10.1016\/j.ajpc.2022.100432_bib0005","first-page":"7","article-title":"\u00dcber die Atherosklerose der Kombattanten (nach Obduktionsbefunden)","volume":"7","author":"M\u00f6nckeberg","year":"1915","journal-title":"Zentralbl Herz Gefasskrankheiten"},{"key":"10.1016\/j.ajpc.2022.100432_bib0006","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/jama.1953.03690120006002","article-title":"Coronary disease among United States soldiers killed in action in Korea; preliminary report","volume":"152","author":"Enos","year":"1953","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ajpc.2022.100432_bib0007","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jama.1971.03180330061012","article-title":"Coronary artery disease in combat casualties in Vietnam","volume":"216","author":"McNamara","year":"1971","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100432_bib0008","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM199806043382302","article-title":"Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa heart study","volume":"338","author":"Berenson","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100432_bib0009","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/CIR.0b013e3182285a81","article-title":"Value of primordial and primary prevention for cardiovascular disease","volume":"124","author":"Weintraub","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1179\/030801878791925921","article-title":"Reflections on cardiovascular diseases","volume":"3","author":"Strasser","year":"1978","journal-title":"Interdiscip Sci Rev"},{"key":"10.1016\/j.ajpc.2022.100432_bib0011","unstructured":"Health E-UDo, Staff HSD, People H. Healthy people 2010: understanding and improving health: health and human services department, 2000."},{"key":"10.1016\/j.ajpc.2022.100432_bib0012","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","article-title":"Defining and setting national goals for cardiovascular health promotion and disease reduction: the American heart association's strategic impact goal through 2020 and beyond","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0013","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","article-title":"Life's Essential 8: updating and enhancing the American heart association's construct of cardiovascular health: a presidential advisory from the American heart association","volume":"146","author":"Lloyd-Jones","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0014","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1161\/CIRCULATIONAHA.105.548206","article-title":"Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age","volume":"113","author":"Lloyd-Jones","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0015","article-title":"ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0016","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1001\/jama.2012.14312","article-title":"Lifetime risk and years lived free of total cardiovascular disease","volume":"308","author":"Wilkins","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100432_bib0017","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019681","article-title":"Estimated impact of achieving optimal cardiovascular health among US adults on cardiovascular disease events","volume":"10","author":"Bundy","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2022.100432_bib0018","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics\u20142022 update: a report from the American heart association","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0019","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/hrt.2007.140905","article-title":"Should the first priority in cardiovascular risk management be those with prior cardiovascular disease?","volume":"95","author":"Kerr","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.ajpc.2022.100432_bib0020","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol","author":"Grundy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0021","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.CIR.0000151788.08740.5C","volume":"111","author":"Leon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0022","series-title":"Proposed national coverage determination for supervised exercise therapy (SET) for symptomatic peripheral artery disease (PAD)","author":"Jensen","year":"2017"},{"key":"10.1016\/j.ajpc.2022.100432_bib0023","article-title":"Exercise-based cardiac rehabilitation for coronary heart disease","volume":"11","author":"Dibben","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajpc.2022.100432_bib0024","article-title":"Exercise-based cardiac rehabilitation for adults with heart failure","volume":"1","author":"Long","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajpc.2022.100432_bib0025","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1136\/heartjnl-2017-312809","article-title":"Cost-effectiveness of cardiac rehabilitation: a systematic review","volume":"104","author":"Shields","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.ajpc.2022.100432_bib0026","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mayocp.2016.10.014","article-title":"Increasing cardiac rehabilitation participation from 20% to 70%: a road map from the million hearts cardiac rehabilitation collaborative","volume":"92","author":"Ades","year":"2017","journal-title":"Mayo Clinic Proc"},{"key":"10.1016\/j.ajpc.2022.100432_bib0027","article-title":"Trends and predictors of participation in cardiac rehabilitation following acute myocardial infarction: data from the behavioral risk factor surveillance system","volume":"7","author":"Peters","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2022.100432_bib0028","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaccas.2022.05.027","article-title":"Novel virtual world-based cardiac rehabilitation program to broaden access to underserved populations: a patient perspective","volume":"4","author":"Content","year":"2022","journal-title":"JACC Case Reports"},{"key":"10.1016\/j.ajpc.2022.100432_bib0029","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2105\/AJPH.49.10.1349","article-title":"Some factors associated with the development of coronary heart disease: six years' follow-up experience in the Framingham study","volume":"49","author":"Dawber","year":"1959","journal-title":"Am J Public Health Nations Health"},{"key":"10.1016\/j.ajpc.2022.100432_bib0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-55-1-33","article-title":"Factors of risk in the development of coronary heart disease\u2013six year follow-up experience. The Framingham study","volume":"55","author":"Kannel","year":"1961","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajpc.2022.100432_bib0031","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/01.CIR.35.4.734","article-title":"Relation of body weight to development of coronary heart disease. The Framingham study","volume":"35","author":"Kannel","year":"1967","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0032","first-page":"811","article-title":"Habitual level of physical activity and risk of coronary heart disease: the Framingham study","volume":"96","author":"Kannel","year":"1967","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.ajpc.2022.100432_bib0033","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.59.1.8","article-title":"Diabetes and cardiovascular risk factors: the Framingham study","volume":"59","author":"Kannel","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0034","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1016\/S0021-9258(19)42341-7","article-title":"Binding and degradation of low density lipoproteins by cultured human fibroblasts: comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia","volume":"249","author":"Goldstein","year":"1974","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpc.2022.100432_bib0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.ge.13.120179.001355","article-title":"The LDL receptor locus and the genetics of familial hypercholesterolemia","volume":"13","author":"Goldstein","year":"1979","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.ajpc.2022.100432_bib0036","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100432_bib0037","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMe1507041","article-title":"Proof that lower is better\u2013LDL cholesterol and IMPROVE-IT","volume":"372","author":"Jarcho","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100432_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-011-0219-7","article-title":"Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges","volume":"14","author":"Sampson","year":"2012","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ajpc.2022.100432_bib0039","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013225","article-title":"Diagnosis and treatment of heterozygous familial hypercholesterolemia","volume":"8","author":"McGowan","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2022.100432_bib0040","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0041","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0042","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jama.2020.14545","article-title":"Trends in blood pressure control among US adults with hypertension, 1999-2000 to 2017-2018","volume":"324","author":"Muntner","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100432_bib0043","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals","volume":"286","author":"Gerstein","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100432_bib0044","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/ajh\/hpab191","article-title":"Hypertension call to action: will we respond to the call with action?","volume":"35","author":"Mayfield","year":"2022","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ajpc.2022.100432_bib0045","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100432_bib0046","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","article-title":"Effects of aspirin for primary prevention in persons with diabetes mellitus","volume":"379","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100432_bib0047","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial","volume":"392","author":"Gaziano","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2022.100432_bib0048","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/jama.2018.20578","article-title":"Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis","volume":"321","author":"Zheng","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100432_bib0049","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jamacardio.2020.4939","article-title":"Value of coronary artery calcium scanning in association with the net benefit of aspirin in primary prevention of atherosclerotic cardiovascular disease","volume":"6","author":"Ajufo","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0050","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1161\/CIRCOUTCOMES.113.000690","article-title":"Use of coronary artery calcium testing to guide aspirin utilization for primary prevention: estimates from the multi-ethnic study of atherosclerosis","volume":"7","author":"Miedema","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ajpc.2022.100432_bib0051","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.119.045010","article-title":"Coronary artery calcium for personalized allocation of aspirin in primary prevention of cardiovascular disease in 2019","volume":"141","author":"Cainzos-Achirica","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0052","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jacc.2022.07.027","article-title":"Aspirin for primary prevention of cardiovascular events in relation to lipoprotein (a) genotypes","volume":"80","author":"Lacaze","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0053","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","article-title":"Rivaroxaban in patients with a recent acute coronary syndrome","volume":"366","author":"Mega","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100432_bib0054","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100432_bib0055","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Anand","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2022.100432_bib0056","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(17)32458-3","article-title":"Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Connolly","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2022.100432_bib0057","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0058","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100432_bib0059","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100432_bib0060","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100432_bib0061","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0062","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome\u2014a new world-wide definition. A consensus statement from the international diabetes federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/j.ajpc.2022.100432_bib0063","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jacc.2015.06.1328","article-title":"The cardiometabolic health alliance: working toward a new care model for the metabolic syndrome","volume":"66","author":"Sperling","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0064","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2006.09.032","article-title":"Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies","volume":"49","author":"Gami","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0065","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.2337\/dcS13-2001","article-title":"Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer","volume":"36","author":"Gallagher","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajpc.2022.100432_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleepe.2022.100022","article-title":"Racial\/ethnic minorities have greater declines in sleep duration with higher risk of cardiometabolic disease: an analysis of the U.S. national health interview survey","volume":"2","author":"Tubbs","year":"2022","journal-title":"Sleep Epidemiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0067","unstructured":"Yeghiazarians Y, Jneid H, Tietjens JR et\u00a0al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American heart association. Circulation;0:CIR.0000000000000988."},{"key":"10.1016\/j.ajpc.2022.100432_bib0068","article-title":"Atherosclerotic cardiovascular disease risk assessment: an American society for preventive cardiology clinical practice statement","volume":"10","author":"Wong","year":"2022","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0069","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0070","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham heart study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0071","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/ije\/dyv337","article-title":"Cohort profile: the Framingham heart study (FHS): overview of milestones in cardiovascular epidemiology","volume":"44","author":"Tsao","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0072","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American college of cardiology\/American heart association task force on practice guidelines","volume":"63","author":"Goff","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0073","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005676","article-title":"Performance of the atherosclerotic cardiovascular disease pooled cohort risk equations by social deprivation status","volume":"6","author":"Colantonio","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2022.100432_bib0074","doi-asserted-by":"crossref","first-page":"456","DOI":"10.7326\/M16-2543","article-title":"Accuracy of cardiovascular risk prediction varies by neighborhood socioeconomic position: a retrospective cohort study","volume":"167","author":"Dalton","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajpc.2022.100432_bib0075","first-page":"e13","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ajpc.2022.100432_bib0076","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0077","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2022.100432_bib0078","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1093\/eurheartj\/ehs230","article-title":"Coronary artery calcium for the prediction of mortality in young adults <45 years old and elderly adults >75 years old","volume":"33","author":"Tota-Maharaj","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2022.100432_bib0079","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jacc.2008.04.004","article-title":"Coronary artery calcium to predict all-cause mortality in elderly men and women","volume":"52","author":"Raggi","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0080","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2021.08.019","article-title":"Modeling the recommended age for initiating coronary artery calcium testing among at-risk young adults","volume":"78","author":"Dzaye","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0081","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jcmg.2020.06.048","article-title":"Warranty period of a calcium score of zero: comprehensive analysis from MESA","volume":"14","author":"Dzaye","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ajpc.2022.100432_bib0082","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.atherosclerosis.2020.11.014","article-title":"Statins and coronary artery calcium: what's the score?","volume":"316","author":"German","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2022.100432_bib0083","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240539","article-title":"Coronary artery calcium testing in low-intermediate risk symptomatic patients with suspected coronary artery disease: an effective gatekeeper to further testing?","volume":"15","author":"Mahmood","year":"2020","journal-title":"Plos One"},{"key":"10.1016\/j.ajpc.2022.100432_bib0084","article-title":"Cardiac CT angiography in current practice: an American society for preventive cardiology clinical practice statement\u2730","volume":"9","author":"Budoff","year":"2022","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0085","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacc.2018.10.066","article-title":"Coronary artery plaque characteristics associated with adverse outcomes in the SCOT-HEART study","volume":"73","author":"Williams","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0086","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0140-6736(15)60291-4","article-title":"CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2022.100432_bib0087","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1161\/CIRCULATIONAHA.116.024360","article-title":"Prognostic value of noninvasive cardiovascular testing in patients with stable chest pain: insights from the PROMISE trial (Prospective multicenter imaging study for evaluation of chest pain)","volume":"135","author":"Hoffmann","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0088","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.atherosclerosis.2011.06.044","article-title":"Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis","volume":"220","author":"Inaba","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2022.100432_bib0089","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.120.011701","article-title":"Association of carotid artery plaque with cardiovascular events and incident coronary artery calcium in individuals with absent coronary calcification: the MESA","volume":"14","author":"Mehta","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.ajpc.2022.100432_bib0090","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jacl.2017.04.121","article-title":"Real-world data to assess changes in low-density lipoprotein cholesterol and predicted cardiovascular risk after ezetimibe discontinuation post reporting of the ezetimibe and simvastatin in hypercholesterolemia enhances atherosclerosis regression trial","volume":"11","author":"Bays","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0091","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics\u20142020 update: a report from the American heart association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0092","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/aje\/kwaa051","article-title":"Burden of peripheral artery disease on mortality and incident cardiovascular events: the multi-ethnic study of atherosclerosis","volume":"189","author":"Unkart","year":"2020","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0093","first-page":"e726","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0094","doi-asserted-by":"crossref","first-page":"e472","DOI":"10.1161\/CIR.0000000000001031","article-title":"2021 Dietary guidance to improve cardiovascular health: a scientific statement from the American heart association","volume":"144","author":"Lichtenstein","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0095","unstructured":"U.S. Department of Agriculture and U.S. Department of health and human services. Dietary guidelines for Americans -tED."},{"key":"10.1016\/j.ajpc.2022.100432_bib0096","article-title":"Practical, evidence-based approaches to nutritional modifications to reduce atherosclerotic cardiovascular disease: an American society for preventive cardiology clinical practice statement","volume":"10","author":"Belardo","year":"2022","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0097","article-title":"Top 10 dietary strategies for atherosclerotic cardiovascular risk reduction","volume":"4","author":"Sikand","year":"2020","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0098","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(22)00122-2","article-title":"Long-term secondary prevention of cardiovascular disease with a mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial","volume":"399","author":"Delgado-Lista","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2022.100432_bib0099","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100432_bib0100","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacl.2018.06.016","article-title":"Clinical and cost benefits of medical nutrition therapy by registered dietitian nutritionists for management of dyslipidemia: a systematic review and meta-analysis","volume":"12","author":"Sikand","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0101","unstructured":"Services USDoHaH. 2018 Physical activity guidelines advisory committee. 2018 Physical activity guidelines advisory committee scientific report. 2018."},{"key":"10.1016\/j.ajpc.2022.100432_bib0102","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005263","article-title":"Physical activity guidelines for Americans from the US department of health and human services","volume":"11","author":"Piercy","year":"2018","journal-title":"Circ Cardiovas Qual Outcomes"},{"key":"10.1016\/j.ajpc.2022.100432_bib0103","doi-asserted-by":"crossref","first-page":"e705","DOI":"10.1161\/CIR.0000000000000749","article-title":"Exercise-related acute cardiovascular events and potential deleterious adaptations following long-term exercise training: placing the risks into perspective\u2013an update: a scientific statement from the American heart association","volume":"141","author":"Franklin","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0104","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s40279-017-0724-0","article-title":"Health benefits of light-intensity physical activity: a systematic review of accelerometer data of the national health and nutrition examination survey (NHANES)","volume":"47","author":"F\u00fcz\u00e9ki","year":"2017","journal-title":"Sports Med"},{"key":"10.1016\/j.ajpc.2022.100432_bib0105","article-title":"Moderate-to-vigorous physical activity and all-cause mortality: do bouts matter?","volume":"7","author":"Saint-Maurice","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2022.100432_bib0106","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/eurheartj\/ehz897","article-title":"Association between physical activity and risk of incident arrhythmias in 402 406 individuals: evidence from the UK Biobank cohort","volume":"41","author":"Elliott","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2022.100432_bib0107","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/jamacardio.2018.4647","article-title":"Extreme physical activity and coronary artery calcification-running heavily and safely with \"Hearts of Stone\"","volume":"4","author":"Lavie","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0108","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2019.0899","article-title":"Association of step volume and intensity with all-cause mortality in older women","author":"Lee","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ajpc.2022.100432_bib0109","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2020.1382","article-title":"Association of daily step count and step intensity with mortality among US adults","volume":"323","author":"Saint-Maurice","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100432_bib0110","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1016\/S2468-2667(21)00302-9","article-title":"Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts","volume":"7","author":"Paluch","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.ajpc.2022.100432_bib0111","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.ypmed.2004.03.006","article-title":"Diet and physical activity counseling during ambulatory care visits in the United States","volume":"39","author":"Ma","year":"2004","journal-title":"Prev Med"},{"key":"10.1016\/j.ajpc.2022.100432_bib0112","doi-asserted-by":"crossref","first-page":"e1389","DOI":"10.1136\/bmj.e1389","article-title":"Effectiveness of physical activity promotion based in primary care: systematic review and meta-analysis of randomised controlled trials","volume":"344","author":"Orrow","year":"2012","journal-title":"Bmj"},{"key":"10.1016\/j.ajpc.2022.100432_bib0113","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1161\/CIR.0000000000000559","article-title":"Routine assessment and promotion of physical activity in healthcare settings: a scientific statement from the American heart association","volume":"137","author":"Lobelo","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0114","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European atherosclerosis society consensus panel","volume":"41","author":"Bor\u00e9n","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2022.100432_bib0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100432_bib0116","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1001\/jama.2020.22258","article-title":"Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial","volume":"324","author":"Nicholls","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100432_bib0117","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jacc.2020.11.079","article-title":"New and emerging therapies for reduction of LDL-cholesterol and apolipoprotein B","volume":"77","author":"Nurmohamed","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0118","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jacc.2021.01.051","article-title":"Emerging RNA therapeutics to lower blood levels of Lp (a): JACC focus seminar 2\/4","volume":"77","author":"Tsimikas","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0119","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.jacc.2021.08.051","article-title":"New therapies for lowering triglyceride-rich lipoproteins","volume":"78","author":"Rosenson","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0120","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.jacc.2021.09.004","article-title":"Familial hypercholesterolemia: jacc focus seminar 4\/4","volume":"78","author":"Brandts","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0121","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","article-title":"Resistant hypertension: detection, evaluation, and management: a scientific statement from the American heart association","volume":"72","author":"Carey","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ajpc.2022.100432_bib0122","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMp1716193","article-title":"Redefining hypertension - assessing the new blood-pressure guidelines","volume":"378","author":"Bakris","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100432_bib0123","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/HYPERTENSIONAHA.116.06587","article-title":"Refractory hypertension","volume":"67","author":"Dudenbostel","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.ajpc.2022.100432_bib0124","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jacc.2020.05.037","article-title":"2020 Expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes: a report of the American college of cardiology solution set oversight committee","volume":"76","author":"Das","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0125","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2022.100432_bib0126","first-page":"S125","article-title":"Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes\u20142022","volume":"45","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajpc.2022.100432_bib0127","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2022.100432_bib0128","doi-asserted-by":"crossref","first-page":"842","DOI":"10.4158\/EP161356.ESGL","article-title":"American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity executive summary","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ajpc.2022.100432_bib0129","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jacc.2017.12.014","article-title":"Metabolic surgery","volume":"71","author":"Pareek","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0130","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1136\/heartjnl-2012-301778","article-title":"Bariatric surgery and cardiovascular outcomes: a systematic review","volume":"98","author":"Vest","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.ajpc.2022.100432_bib0131","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2011.1914","article-title":"Bariatric surgery and long-term cardiovascular events","volume":"307","author":"Sj\u00f6str\u00f6m","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100432_bib0132","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/CIRCULATIONAHA.109.904003","article-title":"Medication adherence in cardiovascular disease","volume":"121","author":"Baroletti","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0133","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jacc.2016.06.005","article-title":"Assessing the impact of medication adherence on long-term cardiovascular outcomes","volume":"68","author":"Bansilal","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0134","first-page":"219","article-title":"Effect of mobile health interventions on the secondary prevention of cardiovascular disease: systematic review and meta-analysis","volume":"33","author":"Gandhi","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0135","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.jacc.2018.04.030","article-title":"Mobile health advances in physical activity, fitness, and atrial fibrillation","volume":"71","author":"McConnell Michael","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0136","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.jacc.2020.01.046","article-title":"Wearable devices for ambulatory cardiac monitoring","volume":"75","author":"Sana","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0137","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.116.025303","article-title":"Improving the cardiovascular health of women in the nation: moving beyond the bikini boundaries","volume":"135","author":"Gulati","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0138","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012873","article-title":"Yentl's Bikini: sex differences in STEMI","volume":"8","author":"Gulati","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2022.100432_bib0139","first-page":"e563","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0140","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics-2022 update: a report from the American heart association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0141","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0142","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCULATIONAHA.108.845792","article-title":"The progression of hypertensive heart disease","volume":"123","author":"Drazner","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0143","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1161\/CIR.0000000000000343","article-title":"Sex differences in the cardiovascular consequences of diabetes mellitus: a scientific statement from the American heart association","volume":"132","author":"Regensteiner","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0144","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2022.100432_bib0145","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.004249","article-title":"Prevalence and management of symptoms associated with statin therapy in community practice: insights from the PALM (Patient and provider assessment of lipid management) registry","volume":"11","author":"Navar","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ajpc.2022.100432_bib0146","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005562","article-title":"Sex differences in the use of statins in community practice","volume":"12","author":"Nanna","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ajpc.2022.100432_bib0147","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jacc.2018.02.032","article-title":"Sex differences in high-intensity statin use following myocardial infarction in the United States","volume":"71","author":"Peters","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0148","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11082196","article-title":"Sex differences in cardiovascular prevention in type 2: diabetes in a real-world practice database","volume":"11","author":"Ramirez-Morros","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajpc.2022.100432_bib0149","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/HJR.0b013e328325d7f0","article-title":"Sex-based differences in premature first myocardial infarction caused by smoking: twice as many years lost by women as by men","volume":"16","author":"Grundtvig","year":"2009","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.ajpc.2022.100432_bib0150","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1016\/j.jacc.2019.03.525","article-title":"Differential risk of ST-segment elevation myocardial infarction in male and female smokers","volume":"73","author":"Palmer","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0151","article-title":"Identification of female-specific risk enhancers throughout the lifespan of women to improve cardiovascular disease prevention","volume":"2","author":"Elder","year":"2020","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0152","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1089\/jwh.2018.7162","article-title":"Is there really increased cardiovascular morbidity in women with polycystic ovary syndrome?","volume":"27","author":"Carmina","year":"2018","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.ajpc.2022.100432_bib0153","doi-asserted-by":"crossref","first-page":"E391","DOI":"10.1503\/cmaj.160744","article-title":"Failure of fertility therapy and subsequent adverse cardiovascular events","volume":"189","author":"Udell","year":"2017","journal-title":"CMAJ"},{"key":"10.1016\/j.ajpc.2022.100432_bib0154","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.fertnstert.2018.10.009","article-title":"Self-reported infertility, metabolic dysfunction, and cardiovascular events: a cross-sectional analysis among U.S. women","volume":"111","author":"Gleason","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajpc.2022.100432_bib0155","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1136\/heartjnl-2015-307563","article-title":"Association between miscarriage and cardiovascular disease in a Scottish cohort","volume":"101","author":"Wagner","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.ajpc.2022.100432_bib0156","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.jacc.2019.09.052","article-title":"Long-term cardiovascular risk in women with hypertension during pregnancy","volume":"74","author":"Honigberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0157","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00125-019-4840-2","article-title":"Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis","volume":"62","author":"Kramer","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.ajpc.2022.100432_bib0158","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007809","article-title":"Preterm delivery and future risk of maternal cardiovascular disease: a systematic review and meta-analysis","volume":"7","author":"Wu","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2022.100432_bib0159","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.hlc.2015.01.004","article-title":"Delivery of a small-for-gestational-age infant and risk of maternal cardiovascular disease\u2013a population-based record linkage study","volume":"24","author":"Ngo","year":"2015","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.ajpc.2022.100432_bib0160","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1136\/heartjnl-2017-312289","article-title":"Women's reproductive factors and incident cardiovascular disease in the UK Biobank","volume":"104","author":"Peters","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.ajpc.2022.100432_bib0161","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1210\/jc.2016-1141","article-title":"Cardiovascular risk in women with premature ovarian insufficiency compared to premenopausal women at middle age","volume":"101","author":"Daan","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajpc.2022.100432_bib0162","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/2047487314556004","article-title":"Collaborators of the Dutch multidisciplinary guideline development group on cardiovascular risk management after reproductive D. Cardiovascular disease risk in women with premature ovarian insufficiency: A systematic review and meta-analysis","volume":"23","author":"Roeters van Lennep","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0163","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012406","article-title":"Age at Menarche and risk of cardiovascular disease outcomes: findings from the national heart lung and blood institute-sponsored women's ischemia syndrome evaluation","volume":"8","author":"Lee","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2022.100432_bib0164","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ypmed.2018.06.014","article-title":"Breastfeeding and later maternal risk of hypertension and cardiovascular disease - the role of overall and abdominal obesity","volume":"114","author":"Kirkegaard","year":"2018","journal-title":"Prev Med"},{"key":"10.1016\/j.ajpc.2022.100432_bib0165","article-title":"Ten things to know about ten cardiovascular disease risk factors - 2022","volume":"10","author":"Bays","year":"2022","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0166","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1016\/j.jacc.2021.06.017","article-title":"Race, ethnicity, hypertension, and heart disease: JACC focus seminar 1\/9","volume":"78","author":"Ogunniyi","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100432_bib0167","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1001\/jama.2019.16932","article-title":"Life expectancy and mortality rates in the United States, 1959-2017","volume":"322","author":"Woolf","year":"2019","journal-title":"Jama"},{"key":"10.1016\/j.ajpc.2022.100432_bib0168","first-page":"1794","article-title":"Victoria declaration on heart health","volume":"147","author":"Farquhar","year":"1992","journal-title":"CMAJ"},{"key":"10.1016\/j.ajpc.2022.100432_bib0169","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/CIRCULATIONAHA.121.053461","article-title":"Avoiding the coming tsunami of common, chronic disease","volume":"143","author":"Califf","year":"2021","journal-title":"Circulation"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667722001167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667722001167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:39:59Z","timestamp":1763005199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667722001167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":169,"alternative-id":["S2666667722001167"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2022.100432","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2022.100432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100432"}}